The global pancreatin market, valued at US$ 101.4 million in 2021, is set to expand at a compound annual growth rate (CAGR) of 5.7% from 2021 to 2031, reaching a projected value of US$ 175.7 million by the end of 2031. Pancreatin, a mixture of digestive enzymes produced by the pancreas, is essential for the breakdown of fats, proteins, and carbohydrates, making it a significant component in the food and pharmaceutical industries. The increasing prevalence of pancreatic diseases and the rising demand for digestive enzyme supplements are key factors driving market growth.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=67292

Market Segmentation

The pancreatin market is segmented based on source, form, and application. Porcine-derived pancreatin dominates the market, accounting for a significant share. This segment is expected to grow at a CAGR of around 5.8% over the forecast period. In terms of form, the powder segment holds the largest market share, with a value of over US$ 83.6 million in 2021. The pharmaceutical application segment is the frontrunner, holding 86.4% of the market value share, driven by the enzyme's extensive use in treating digestive disorders.

Regional Analysis

North America and Europe are the leading markets for pancreatin, collectively accounting for more than 57% of the global market value in 2021. The high awareness of health supplements and their therapeutic benefits in these regions contribute to their dominance. The European market, valued at over US$ 33.4 million in 2021, is particularly notable, with Germany representing 15.8% of the global market share.

Competitive Landscape

The pancreatin market is characterized by intense competition, with key players focusing on expanding their product offerings and improving production processes. Companies like Biozyme, Bioseutica, and Bio Basic Inc. are investing in R&D to develop high-quality, cost-effective pancreatin products. Strategic initiatives such as Biozyme's Pancreas Process Program, which reduces processing costs by expanding raw pancreas processing in the U.S., exemplify efforts to enhance market competitiveness.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453